Ocular Trauma Devices Market Size, Share & Trends Analysis Report By Device Type (Implants, Instruments, Disposables), By Indication (Blunt Trauma, Chemical Trauma, Sharp Trauma), By End-Use, By Region, and Segment Forecasts, 2022 - 2030

Ocular Trauma Devices Market Size, Share & Trends Analysis Report By Device Type (Implants, Instruments, Disposables), By Indication (Blunt Trauma, Chemical Trauma, Sharp Trauma), By End-Use, By Region, and Segment Forecasts, 2022 - 2030

Ocular Trauma Devices Market Growth & Trends

The global ocular trauma devices market size is expected to reach USD 6.56 billion by 2030, registering a CAGR of 7.2% from 2022 to 2030, according to a new report by Grand View Research, Inc. Ocular trauma is sometimes referred to as non-penetrating trauma or blunt force trauma to the eye area. Combinations of forces, including acceleration and deceleration, shearing, and crushing pressure can result in ocular trauma. Ocular trauma can cause damage to the eye, the eyelid, and the surrounding bones resulting in blunt eye injuries such as globe exploding, retinal separation, hyphemia, frontal eye hemorrhage, retrobulbar hemorrhage, fracture of the orbit, accidental glaucoma, vitreous bleeding, corneal injuries, and cataract. According to a report by the vision center, around 95% of ocular trauma occurs in men under the age of 30, often caused by interpersonal violence.

Healthcare delivery was severely damaged due to the COVID-19 pandemic. Despite an overwhelming number of COVID-19 cases, ophthalmic clinics witnessed a sharp reduction in outpatient visits and operations, and hospitals lost a large amount of revenue in the initial stage of the pandemic. The COVID-19 pandemic had a negative effect on the sales of ocular devices such as contact lenses, implants, and ocular instruments. Ophthalmic clinics stayed closed throughout the lockdown period since ophthalmologists and healthcare professionals faced the biggest risk of spreading the virus. As a result, there was a decrease in the demand for ocular care products. However, the market is expected to regain its pre-pandemic position in the coming years due to the relaxation of regulations at present and the considerable economic recovery.

Several organizations along with ophthalmologists have launched campaigns and initiatives to increase awareness about ocular care and eye health among the general public. These organizations provide seminars, tutorials, and workshops that teach technicians how to utilize different pieces of ophthalmic equipment. Such programs aid in raising awareness of eye conditions and the availability of diagnostic tools.

Ocular Trauma Devices Market Report Highlights

  • Based on device type, the implants segment accounted for the largest market share of 45.0% in 2021 and is expected to witness the fastest growth with a CAGR of 8.0% over the forecast period from 2022 to 2030 pertaining to the rising incidence of diabetic retinopathy due to growing prevalence of diabetes and adoption of a sedentary lifestyle
  • Based on the indication, the blunt trauma segment dominated the market with a revenue share of 47.5% in 2021. The increase in the elderly population will fuel the expansion of the segment. Combinations of forces, including acceleration and deceleration, shearing, and crushing pressure can result in blunt trauma.
  • On the other hand, the sharp trauma segment is expected to witness the fastest CAGR of 8.7% during the forecast period owing to the increasing number of cases of sharp object eye injuries in the workplace.
  • Based on end-use, the hospital segment accounted for a market share of 50.2% in 2021, owing to the rising adoption of advanced ophthalmic technology in hospitals and the availability of affordable and efficient treatment options
  • The ophthalmic clinics segment is expected to witness the fastest CAGR of 7.9% during the forecast period from 2022 to 2030 due to the increasing need for eye care services in outlying locations
  • North America accounted for the largest revenue share of 43.8% in 2021 attributed to the rise in the elderly population, increased incidence of eye-related problems, and growing healthcare costs. Asia Pacific is anticipated to witness a rapid CAGR of 9.6% over the forecast period owing to a significant rise in the number of elderly people in the region. Developing nations such as China and India are predicted to have the highest development in this region.
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Solutionology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Medical Biomimetics Market Variables, Trends, & Scope
4.1 Medical Biomimetics Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Market Driver Analysis
4.3.1 Growing Advancement In Nanotechnology
4.3.2 Increasing Demand For Prostheses And Implants
4.3.3 Rise In Research And Development Activities Associated With Medical Biomimetics
4.4 Market Restraint Analysis
4.4.1 Stringent Regulatory Framework
4.5 Key Opportunities
4.5.1 Growing Tissue Engineering Market
4.6 Medical Biomimetics Market - Pestle Analysis
4.7 Industry Analysis - Porter’s
4.8 Major Deals And Strategic Alliances Analysis
4.8.1 Joint Ventures
4.8.2 Mergers And Acquisitions
4.8.3 Licensing And Partnership
4.8.4 Technology Collaborations
4.8.5 Strategic Divestments
4.9 COVID-19 Impact Analysis
Chapter 5 Medical Biomimetics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
5.1 Global Medical Biomimetics Market: Product Movement Analysis
5.2 Cardiovascular
5.2.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Orthopedic
5.3.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Ophthalmology
5.4.1 Ophthalmology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Dental
5.5.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Others
5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Medical Biomimetics Market- Segment Analysis, By Application, 2018 - 2030 (Usd Million)
6.1 Medical Biomimetics Market: Application Movement Analysis
6.2 Wound Healing
6.2.1 Wound Healing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Tissue Engineering
6.3.1 Tissue Engineering Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Drug Delivery
6.4.1 Drug Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Other Applications
6.5.1 Other Applications Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Medical Biomimetics Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)
7.1 Medical Biomimetics Market: Regional Movement Analysis
7.2 North America
7.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 Uk Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Market Estimates And Forecast, 2018-2030
7.4.5 South Korea
7.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.6 Australia
7.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Market Estimates AND FORECAST, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Middle East & Africa (Mea)
7.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.4 Uae
7.6.4.1 Uae Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Public Companies
8.1.1 Company Market Position Analysis
8.1.2 Competitive Dashboard Analysis
8.1.3 Strategic Framework
8.2 Private Companies
8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
8.2.2 Regional Network Map
8.3 Company Profiles
8.3.1 OTSUKA MEDICAL DEVICES GROUP
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 STRYKER
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 ABBOTT
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 AVINENT SCIENCE AND TECHNOLOGY
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 SYNTOUCH INC
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 OSTEOPORE INTERNATIONAL PTE LTD
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 VANDSTROM, INC.
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
8.3.8 BIOMIMETICS TECHNOLOGIES INC
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 SWEDISH BIOMIMETICS 3000 APS
8.3.9.1 Company Overview
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 LIFEMATRIX
8.3.10.1 Company Overview
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.10.4 Strategic Initiatives
8.3.11 KEYSTONE DENTAL GROUP
8.3.11.1 Company Overview
8.3.11.2 Financial Performance
8.3.11.3 Product Benchmarking
8.3.11.4 Strategic Initiatives
8.3.12 CURASAN, INC.
8.3.12.1 Company Overview
8.3.12.2 Financial Performance
8.3.12.3 Product Benchmarking
8.3.12.4 Strategic Initiatives
8.3.13 CORNEAT VISION
8.3.13.1 Company Overview
8.3.13.2 Financial Performance
8.3.13.3 Product Benchmarking
8.3.13.4 Strategic Initiatives
8.3.14 NANOHIVE MEDICAL LLC
8.3.14.1 Company Overview
8.3.14.2 Financial Performance
8.3.14.3 Product Benchmarking
8.3.14.4 Strategic Initiatives
8.3.15 ZIMMER BIOMET
8.3.15.1 Company Overview
8.3.15.2 Financial Performance
8.3.15.3 Product Benchmarking
8.3.15.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings